Top Markets
Coin of the day
InnoCan Pharma Corporation InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO
Rank in Stocks #33470
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Share Price
$1.69
Last synced: 2026-08-13
Market Cap
$7.59M
Change (1 day)
2.22%
Change (1 year)
-84.04%
Country
CA
Trade InnoCan Pharma Corporation (INNO)

Category

EPS for InnoCan Pharma Corporation (INNO)
EPS as of 2026 TTM: 0
According to InnoCan Pharma Corporation latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for InnoCan Pharma Corporation from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors